DATECAN initiative publishes guidelines for time-to-event end point definitions in breast cancer trials
2015-05-19
(Press-News.org) The DATECAN initiative, Definition for the Assessment of Time-to-event Endpoints in CANcer trials, has published Guidelines for time-to-event end point definitions in breast cancer trials in a recent issue of the Annals of Oncology. Standardized definitions can help researchers to more easily compare the results of clinical trials. The guidelines developed by the DATECAN initiative can help researchers to have a more uniform usage of key endpoints in the design, conduct, and reporting of clinical trials for patients with breast cancer.
DATECAN was initiated by statisticians and methodologists from UNICANCER under the leadership of the EORTC (European Organisation for Research and Treatment of Cancer) and with a grant from the ligue Nationale contre le cancer and the support of INCa (Institut National du Cancer). Members of the DATECAN leadership team include Prof Franck Bonnetain of the University Hospital of Besancon and the GERCOR INCa Datacenter, Dr Laurence Collette of EORTC Headquarters in Brussels, Dr Simone Mathoulin-Pelissier and Dr Carine Bellera of the Institut Bergonié in Bordeaux, Dr Sophie Gourgou of the Biometrics Unit at the Montpellier Cancer Institute, and Dr Andrew Kramar of the Cancer Care Center of Lille.
Prof Franck Bonnetain points out, "DATECAN should help us to elaborate recommendations that can then be used as guidelines by researchers participating in clinical trials. For this purpose, we are using a formal consensus process to obtain standardized consensus definitions of time-to-event end points for several cancer types: pancreas, breast, sarcoma/GIST, stomach, esophagus, head and neck, colon, rectum, kidney, bladder, and lung (Bellera CA, Pulido M, Gourgou S, et al. Eur J Cancer 2013). Our most recent publication focuses on the definition of time-to-event end points, as primary or secondary end points, used in randomized clinical trials for patients with breast cancer in non-metastatic and metastatic settings."
Dr Sophie Gourgou, corresponding author of these DATECAN guidelines for time-to-event end point definitions in breast cancer trials says, "Overall survival is often the endpoint used for cancer clinical trials, but today, end points such as disease-free survival are becoming increasingly common. One reason for this is that treatments are now more effective, especially in breast cancer, mortality is lower, and other measures of a treatment's efficacy are needed. The problem is, these newer "time-to-event" end points are not well defined, so our ability to interpret results and make cross-trial comparisons is compromised."
Guidelines published previously by the DATECAN initiative include "Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)" for sarcoma (gastrointestinal stromal tumors) by Bellera et al. (Ann Onc 2015 26;(5):865-872), "Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)" for pancreas by Bonnetain et al (Eur J Cancer 2014 50;(17):2983-2993), and "International Guidelines For The Definition of Time to Event Endpoints (Tee) in Renal Cell Cancer Randomised Clinical Trials: Results Of The Datecan Project" in Annals of Oncology by Kramar et al. (Ann Onc 2014 25;(Suppl 4): iv280-iv304, 2014).
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-19
A new study delineates a sequential pattern of changes in the intestinal microbial population of patients recovering from cholera in Bangladesh, findings that may point to ways of speeding recovery from the dangerous diarrheal disease. The report also finds what appear to be consistent differences between the gut microbial population - also called the microbiota - of individuals in developed countries like the U.S. and those the developing world and provides some of the most complete evidence that the gut microbiota usually return to normal after cholera infection. Their ...
2015-05-19
A team led by researchers from UC San Francisco, Organic Health Response, and Microclinic International is reporting results of a study that showed significant benefits of microclinics -- an innovative intervention that mobilized rural Kenyan HIV patients' informal social networks to support their staying in care.
The results showed that microclinics cut in half the normal rate of disengagement from care, which was defined as missing a clinic appointment by 90 days or more, when compared to the control group, and reduced the perceived stigma of HIV by 25 percent within ...
2015-05-19
A new study has found that endocrine disrupting chemicals--which can interfere with the actions of hormones in the body--are present in some plastic teethers for babies, and the chemicals can leach out of the products.
Investigators detected significant endocrine activity in 2 of 10 plastic teethers. One teether contained methyl-, ethyl- and propylparaben, while the second contained at least 6 different endocrine disrupting compounds that remain so far unidentified.
"The good news is that most of teethers we investigated did not contain endocrine disruptors. However, ...
2015-05-19
An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines.
Associate Professor Manoj Gambhir, from Monash University's Department of Epidemiology and Preventive Medicine, is part of the team working on the research. Led by University of Texas Austin researcher Dr Steve Bellan, and in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), the study on the design of CDC's vaccine trial in Sierra Leone is published in The Lancet Infectious Diseases.
Safe and effective vaccines could help ...
2015-05-19
Swedish clinicians recently reported the first live birth after uterus transplantation, which was followed by two more uneventful births and another pregnancy that is near term.
In a new Acta Obstetricia et Gynecologica Scandinavica commentary, one of the leaders behind these successes, Professor Mats Brannström, provides insights into how the Swedish uterus transplant project was initiated and its long research journey that spans over more than a decade. The first clinical uterus transplantation trial, which enrolled nine women, was initiated in early 2013 and ...
2015-05-19
The anti-epilepsy drug valproate should be avoided whenever possible in women who may become pregnant due to a high risk of malformations and developmental problems in babies who are exposed to the drug before birth.
The guidance comes from a joint task force of the Commission of European Affairs of the International League Against Epilepsy and the European Academy of Neurology. In an Epilepsia paper, the task force notes that it is also important that those women who need valproate to control their seizures are not denied the most effective treatment, as uncontrolled ...
2015-05-19
Women with polycystic ovary syndrome, a hormonal disorder that affects 5% to 10% of the female population of fertile age, often experience sexual dysfunction and low self-esteem, but a new study shows that physical resistance training can help.
Women who participated in physical resistance training--which included upper body, lower body, and abdominal exercises--experienced considerable improvements related to sexual function, desire, arousal, lubrication, and pain, as well as decreases in anxiety and depression.
The authors noted that the Journal of Sexual Medicine ...
2015-05-19
Toxins known as perfluoroalkyl substances have become virtually ubiquitous throughout the environment, and various national and international voluntary phase-outs and restrictions on these compounds have been implemented over the last 10 to 15 years.
Investigators who examined trends in the accumulation of these toxins in the eggs of four species of aquatic birds from the Pacific coast of Canada from the early 1990s to 2011 report that the concentrations of some of these compounds are decreasing in line with manufacturing phase-outs, while others continue to increase ...
2015-05-19
SAN DIEGO, Calif. (May 18,2015) -- The massive, federally funded anti-smoking campaign "Tips From Former Smokers" -- "Tips" for short -- fizzled more than it popped. That's the conclusion behind research published this week in the American Journal of Preventive Medicine by San Diego State University public health researcher John W. Ayers, along with a team of investigators at the Santa Fe Institute and University of Illinois Chicago.
In the new study the team was able to look at the first two years of the campaign for the first time by monitoring the nation's internet ...
2015-05-19
Washington, DC (May 19, 2015) -- Use of computer-assisted propofol sedation for routine upper endoscopy and colonoscopy reduced recovery room time by almost 20 percent, according to a study (abstract 1054) released today at Digestive Disease Week® (DDW) 2015. The study, conducted by researchers at Virginia Mason Medical (VMMC) Center, Seattle, WA, showed the process yielded a better recovery experience than the commonly used combination of midazolam and fentanyl.
"Some patients do not respond well to sedation with midazolam and fentanyl, and others find that these ...
LAST 30 PRESS RELEASES:
[Press-News.org] DATECAN initiative publishes guidelines for time-to-event end point definitions in breast cancer trials
